Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Complement Component C3: A Novel Biomarker Participating in the Pathogenesis of Non-alcoholic Fatty Liver Disease

29 Jul 2021

Abstract excerpt

Non-alcoholic fatty liver disease (NAFLD) is currently the most common cause of chronic liver disorder worldwide. The pathological spectrum of NAFLD ranges from simple steatosis to non-alcoholic steatohepatitis (NASH) that induces progressive liver cirrhosis and eventually hepatocellular carcinoma (HCC). However, the molecular mechanisms driving the transformation of NASH are obscure. There is a compelling need...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hepatitis B Virus Studies
Share to Liver Disease and Transplantation
Share to Liver Disease Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34395461
DOI: 10.3389/fmed.2021.653293

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Complement Component C3: A Novel Biomarker Participating in the Pathogenesis of Non-alcoholic Fatty Liver DiseasePMID 34395461Read ↗

Nonalcoholic fatty liver disease.Semantic proximity Read ↗

Causal Association between Circulating Complement Components and Non-Viral Liver Diseases and Their Potential as Therapeutic Targets: An Integrated Analysis Based on Multi-omics DataSemantic proximity Read ↗

The complement component C3a fragment is a potential biomarker for hepatitis C virus-related hepatocellular carcinomaSemantic proximity Read ↗

An update on the role of complement in hepatocellular carcinomaSemantic proximity Read ↗

The greater impact of PNPLA3 polymorphism on liver-related events in Japanese non-alcoholic fatty liver disease patients: A multicentre cohort study.Semantic proximity Read ↗

The role of the complosome in health and diseaseSemantic proximity Read ↗

Protein-centric omics analysis reveals circulating complements linked to non-viral liver diseases as potential therapeutic targetsSemantic proximity Read ↗

Diagnostic and Prognostic Significance of Complement in Patients With Alcohol‐Associated HepatitisSemantic proximity Read ↗

Molecular Pathogenesis of Nonalcoholic Steatohepatitis- (NASH-) Related Hepatocellular CarcinomaSemantic proximity Read ↗

PNPLA3 genotype and fibrosis-4 index predict cardiovascular diseases of Japanese patients with histopathologically-confirmed NAFLD.Semantic proximity Read ↗

Novel Aspects in the Pathogenesis of Nonalcoholic Steatohepatitis.Semantic proximity Read ↗

Elevated serum complement factors 3 and 4 are strong inflammatory markers of the metabolic syndrome development: a longitudinal cohort studySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.